Gallagher Duncan

Track

Insider profile

Performance

Overall performance
1.0
Performance over holding periods
1.0
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gallagher Duncan's trades of Health Catalyst Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
384.16
Quantity 63,275 +1.4%
Value US$1,634,308
Transaction date
Proposed sale
Price
281.92
Quantity 60,850
Value US$1,195,818
Transaction date
Planned sale
Price
155.78
Quantity 24,839 -36.4%
Value US$4,259,882
Transaction date
Proposed sale
Price
7.09
Quantity 4,500
Value US$31,905
Transaction date
Purchase
Price
11.63
Quantity 6,600 +22.9%
Value US$76,751
Transaction date
Purchase
Price
11.69
Quantity 8,400 +41.2%
Value US$98,196
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-02 2024-12-30
PlS Planned sale
63,275 +1.4%
384.16
US$1,634,308 		63,275 +1.4% 384.16 US$1,634,308
2024-12-30 2024-12-30
PrS Proposed sale
60,850
281.92
US$1,195,818 		60,850 281.92 US$1,195,818
2024-12-27 2024-12-23
PlS Planned sale
24,839 -36.4%
155.78
US$4,259,882 		24,839 -36.4% 155.78 US$4,259,882
2024-12-23 2024-12-23
PrS Proposed sale
4,500
7.09
US$31,905 		4,500 7.09 US$31,905
2022-08-19 2022-08-19
B Purchase
6,600 +22.9%
11.63
US$76,751 		6,600 +22.9% 11.63 US$76,751
2022-08-19 2022-08-18
B Purchase
8,400 +41.2%
11.69
US$98,196 		8,400 +41.2% 11.69 US$98,196